CBD and Legal Cannabis

4Front Ventures Corp. Further Strengthens Massachusetts Footprint, Closes Accretive Acquisition of New England Cannabis Corporation

THE PARENT COMPANY ANNOUNCES VOLUNTARY EXTENSION OF BOARD OF DIRECTOR AND LEADERSHIP TEAM LOCK-UP AGREEMENTS

DRUNK ELEPHANT ARRIVES AT SHOPPERS DRUG MART

Apollon Formularies Announces Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas, MD Anderson Cancer Center in Houston, Texas to the Board of Directors

Brains Bioceutical receives official confirmation of Valid Novel Foods Application from the UK FSA Commission

Apollon Formularies- CEO Review of 2021

Researchers probe the potential impact of medicinal cannabis on Long COVID symptoms

High Tide Opens New Canna Cabana Location in Regina, and Provides Timing for Release of Fourth Quarter and Fiscal Year 2021 Financial Results and Webcast

Cantourage brings first Ugandan medical cannabis to Germany through partnership with Israel’s Together Pharma

Apollon Formularies Plc Appointment of Non-Executive Director